688578.SS
688578.SS
CNE100005XJ7
SHANGHAI ALLIST PHARMACEUTICALS
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 5.187.338.134 3.557.930.156
45.8%
Cost of Revenue 164.579.753 143.485.827
14.7%
Gross Profit 5.022.758.381 3.414.444.329
47.1%
2.541.392.875 1.877.232.255
35.4%
Operating Income 2.481.365.506 1.537.212.073
61.4%
Pretax Income 2.544.937.734 1.618.521.345
57.2%
Net Income Common Stockholders 2.189.104.957 1.429.847.079
53.1%
-- --
--
-- --
--
ende